Unfortunately there is no clear information on the status of the BCG shortage in January 2025. However, a new manufacturing plant was scheduled to open in 2024 which hopefully helped address the shortage that was causing split dosages of BCG. The BCG shortage has impacted treatment, requiring split or reduced dosages for Show Full Answer

Unfortunately there is no clear information on the status of the BCG shortage in January 2025. However, a new manufacturing plant was scheduled to open in 2024 which hopefully helped address the shortage that was causing split dosages of BCG. The BCG shortage has impacted treatment, requiring split or reduced dosages for some patients. Immunotherapies like nadofaragene firadenovec and nogapendekin alfa inbakicept have shown promise in clinical trials when used together with BCG for people who don't respond sufficiently to BCG alone.

 This AI-generated response comes from MyBladderCancerTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

MyBladderCancerTeam

Immunotherapy for Bladder Cancer: Success Rates and More